Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 9/16 August 2014, Vol 293, No 7822/3

Sort by: Newest first Oldest first A-Z Z-A

  • Helen Gordon

    Providing standards and resources — and paying tribute Subscription

    7 AUG 2014 12:00 By Helen Gordon

    RPS chief executive Helen Gordon looks at initiatives to provide the professional leadership pharmacists seek.

  • Trichophyton interdigitale, the fungus responsible for athlete's foot.

    Over-the-counter treatments for athlete's foot Subscription

    7 AUG 2014 By Sai-Ling Ho, Nina Walming
    Comments (2)

    This fungal skin infection is estimated to affect more than 15% of the world’s population. Make sure your pharmacy team knows how to advise patients in managing this common condition.

  • Nicola Clargo, clinical pharmacist at First Databank

    Quality control of clinical information Subscription

    7 AUG 2014 By Jeff Mills

    Pharmacist Nicola Clargo describes her chance career in medical informatics and how it gives her the opportunity to make a difference to patient safety.

  • RPS Faculty crest

    Community pharmacy handbook launched by RPS Faculty Subscription

    7 AUG 2014 By Jeff Mills

    Starting to build a professional portfolio can be daunting but the RPS Faculty has a new resource for pharmacists in the community.

  • Close up of a lung-on-chip linked to a cyclic suction - organ on chip

    Organ-on-chip technology to revolutionise drug development Subscription

    7 AUG 2014 By Janna Lawrence

    Pioneering work creating organ models aims to predict the human response to a protein in order to assess whether it is a suitable drug target.

  • Care homes should use local pharmacies

    Care homes are better off with local pharmacies Subscription

    7 AUG 2014 By Mimi Lau
    Comments (3)

    National pharmaceutical providers can cut costs, but it is the personal touch and higher quality of care provided by local pharmacies that care homes should consider. 

  • Free Community Pharmacy Scotland membership for technicians Subscription

    7 AUG 2014

    Community Pharmacy Scotland (CPS) is offering free associate membership for pharmacy technicians in Scotland. Further information and an application form are available from the CPS website.

  • Cover of the 'Medicines, Ethics and Practice’ (MEP), the professional guide for pharmacists

    Explore the latest MEP Subscription

    7 AUG 2014 By Rakhee Amin

    The 38th edition of ‘Medicines, Ethics and Practice’ was distributed to RPS members in July. Rakhee Amin, on behalf of the RPS Support team, explains what is new in the resource.

  • Primary care on a scrabble board

    Help is needed for patients to understand the scope of pharmacy services

    7 AUG 2014
    Comments (1)

    Patients and the public could do with more information about the clinical role of pharmacists — but more research is needed, too.

  • Berwick report messages remain relevant a year on

    7 AUG 2014

    The lessons from Mid Staffs should resonate beyond England and more widely than hospital care.

  • Verifying genuine pharmaceutical products will be difficult to implement Subscription

    7 AUG 2014 10:15 By Umakant Patel
    Comments (1)

    In most big IT projects software providers have over promised and under delivered and at a far higher final cost. I do not believe it will be any different when it comes to verifying genuine pharmaceutical products (2014;293:587). One billion items are dispensed every year. Assuming it takes one second to check each item physically, this equates to about 280,000 hours of labour.

  • A safe service does not mean it is a good service Subscription

    7 AUG 2014 10:15

    “Surely pharmacists should have been consulted?” writes Graham Phillips (2014;293:85) in his blog about the new General Pharmaceutical Council (GPhC) inspection model for community pharmacies. He considers it unjustified to conclude that only 1 in 30 pharmacies in the UK is “good”. In fact, pharmacists were consulted. I was on the

  • Is it not time registered pharmacy technicians are allowed to join the RPS? Subscription

    7 AUG 2014 10:14 By Howard McNulty

    As one of many who advocated that registered pharmacy technicians should be able to join the new professional body for pharmacy in the past, I was disappointed that the then new Royal Pharmaceutical Society decided not to allow it.

  • Tuesday 2 December: RCN/Royal Pharmaceutical Society Joint Conference Subscription

    7 AUG 2014 10:13

    “Working Together to Help Patients Make the most of Medicines” by the RPS and the RCN. Confirmed speakers include Simon O-Neill, Director of Care Policy and Intelligence, Diabetes UK. Royal College of Nursing, 20 Cavendish Square, London W1G 0RN. Buffet 12.40pm, meeting 9.30am–16.30pm.

  • Zameer Choudrey, CEO of Bestway Group

    Bestway aims high in the UK pharmacy market

    5 AUG 2014 20:30 By Elizabeth Sukkar

    How will Bestway, new owner of the UK’s third largest pharmacy chain, perform in the pharmacy market? And, crucially, will it change the Co-operative business model?

  • Genomics biomarker good practice consultation Subscription

    5 AUG 2014 17:06

    The European Medicines Agency (EMA) has produced a concept paper for consultation on good practice in the use of genomic data and biomarkers in medicines development and safety monitoring. Responses to the consultation should be sent to

  • Gastro-oesophageal reflux in children and young people Subscription

    5 AUG 2014 16:28

    The National Institute of Health and Care Excellence (NICE) has published draft guidance on the recognition, diagnosis and management of gastro-oesophageal reflux disease in children and young people. This includes gastro-oesophageal reflux in babies. The guidance is open for consultation on the NICE website until 25 September 2014.

  • Preregistration survey Subscription

    5 AUG 2014 16:22

    The General Pharmaceutical Council (GPhC) has launched a preregistration survey for trainees who sat the registration assessment on 27 June 2014 and undertook preregistration training in the 2013/2014 training year. The survey will help to improve the GPhC’s understanding of key trends, issues and themes in preregistration training. It is part of a three-year project that started with their first survey of preregistration trainees in 2013. The survey is available on the

  • Contraindications for Eviplera Subscription

    5 AUG 2014 16:22

    Additions have been made to the list of mutations that exclude patients with HIV from treatment with Eviplera (emtricitabine/rilpivirine/tenofovir; Gilead). These are the tenofovir resistance-associated substitution K70E, and the combination of L100I+K103N as a rilpivirine resistance-associated substitution.

  • Drug tariff price updates: July 2014 Subscription

    5 AUG 2014 15:21

    The Department of Health and National Assembly for Wales have agreed concessionary prices for the following items for July 2014 prescriptions: loperamide capsules 2mg, now £2.13; hydrocortisone tablets 10mg, now £58.52; pizotifen tablets 500μg and 1.5mg, now £7.50 and £7.60, respectively.

  • Anafranil overdose Subscription

    5 AUG 2014 15:16

    The summary of product characteristics for Anafranil (clomipramine hydrochloride; Novartis) slow-release tablets 75mg now states that rare cases of pharmacobezoar, of varying severity including fatal outcome, have been reported in association with overdose of sustained release Anafranil. Further information about the pharmacobezoar is available in the updated SPC.

  • Prednisolone shelf life Subscription

    5 AUG 2014 15:14

    The shelf life for Deltacortril (prednisolone; Alliance) and prednisolone (Alliance) gastro-resistant tablets 2.5mg has been increased from 24 to 36 months, according to the updated summaries of product characteristics.

  • Eliquis new indication Subscription

    5 AUG 2014 14:50

    Eliquis (apixaban; Bristol-Myers Squibb) is now indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of reccurent DVT and PE, according to the updated summary of product characteristics. New information on the dosing of apixaban for these indications has also been added to the SPC.

  • Whistleblowing resource Subscription

    5 AUG 2014 14:48

    The charity, Pharmacist Support, has launched a new fact sheet for pharmacists about whistleblowing. It covers topics such as how to deal with bullying after whistleblowing or dismissal from work after whistleblowing. 

  • Adverse reactions for Roche's Herceptin Subscription

    5 AUG 2014 12:16

    Nasopharyngitis, thrombocytopenia, weight loss, anorexia, insomnia, paraesthesia, dysgeusia, stomatitis, palmar-plantar erythrodysesthesia syndrome and peripheral oedema are now listed as very common adverse reactions on the summary of product characteristics for Roche’s Herceptin (trastuzumab). Pleural effusion, pharyngitis and pneumonia are now listed as common adverse reactions.

  • July EMA decisions Subscription

    5 AUG 2014 12:14

    Janssen Cilag’s Imbruvica (ibrutinib) has been recommended for authorisation by the European Commission for the treatment of relapsed or refractory mantle cell lymphoma (MCL) and chronic lymphocytic leukaemia (CLL), in this month’s decisions from the European Medicines Agency (EMA). Gilead’s Zydelig (idelalisib) has also been recommended for approval for the treatment of patients with CLL and patients with refractory follicular lymphoma.

  • Buccolam oromucosal solution recall Subscription

    5 AUG 2014 12:02

    The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medicines recall for specific batches of ViroPharma’s Buccolam oromucosal solution (midazolam hydrochloride). This is because a routine inspection of the company’s contract manufacturing site in the UK identified the possibility of chemical contamination. Further information is available from the

  • Klaricid tablets discontinued Subscription

    5 AUG 2014 11:59

    Abbott has discontinued Klaricid (clarithromycin) tablets 250mg x 14 and 500mg x 14. Further information on 01628 773355.

  • Leflunomide recall Subscription

    5 AUG 2014 11:58

    The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led drug recall for a specific batch of leflunomide (Medac) film-coated tablets 20mg. This is because the affected batch, which has inadvertently been distributed in the UK, is labelled for Poland/The Czech Republic/Slovakia. Further information is available from the

  • Changes to vaccine schedules Subscription

    5 AUG 2014 11:12

    Public Health England has announced changes to the meningococcal C conjugate vaccination schedule. The primary vaccine should now be given to infants at three months, and boosters should be given at 12–13 months, around 14 years and to first-time university entrants from 1 August 2014. More detail is available on the PHE website.

  • Lamisil cream discontinued Subscription

    5 AUG 2014 10:25

    Novartis has discontinued Lamisil (terbinafine hydrochloride) cream 15g. Lamisil cream 30g is unaffected. Further information is available on 01276 687202.

  • AWMSG decisions Subscription

    5 AUG 2014 10:13

    The following medicines have been approved for use in NHS Wales by the All Wales Medicines Strategy Group (AWMSG): eltrombopag to treat thrombocytopenia in adults with hepatitis C infection where the degree of thrombocytopenia is compromising the efficacy of interferon; imatinib for adjuvent treatment of KIT-positive gastrointestinal stromal tumours; Eviplera (emtricitabine, rilpivirine and tenofovir; Gilead) for treatment-experienced adults infected with HIV type 1; and velaglucerase ...

  • Bonviva tablets discontinued Subscription

    5 AUG 2014 9:36

    Roche has discontinued Bonviva (ibandronic acid) tablets 150mg x 3. The single tablet packs and the pre-filled syringe 3mg/ml will continue to be available. Medical information on 0800 328 1629.

  • Rivotril tablets discontinued Subscription

    5 AUG 2014 9:34

    Roche will discontinue Rivotril (clonazepam) tablets 0.5mg and 2mg on 31 August 2014. Medical information on 0800 328 1629.

  • Revised malaria prevention guidelines for UK travellers Subscription

    5 AUG 2014 9:27

    Public Health England (PHE) has updated its guidance on malaria prevention for healthcare professionals advising those travelling from the UK to malaria-endemic areas. The guidance is available from the PHE website.

  • The RPS policy on assisted suicide addresses many questions Subscription

    4 AUG 2014 18:00 By Charles Willis, Aileen Bryson
    Comments (1)

    Although it was good to see an update on the progress of the Westminster private members’ bill on assisted dying reported in last weeks’ editorial (2014;293:98) we were disappointed that no mention was made of the Royal Pharmaceutical Society policy and the amount of work RPS staff have already undertaken to support the profession, should this legislation be passed. 

  • Frederick Norman Harrison dies Subscription

    4 AUG 2014 14:22

    On 22 July, Frederick Norman Harrison, aged 98, of 127 Main Road, Drax, Selby, North Yorkshire YO8 8NJ. Mr Harrison registered in 1938 and left the Society in 2007.

  • Derek Mace dies Subscription

    4 AUG 2014 14:21

    On 15 July, Derek Mace, aged 87, of Alwoodley, Hollytree Road, Woolton, Liverpool L25 5PA. Mr Mace registered with the Society in 1953.

  • Anopheles minimus, mosquito causing malaria

    Artemisinin-resistant malaria ‘widespread’ in Southeast Asia

    1 AUG 2014 14:40 By Joanna Lyford

    Researchers call for radical measures to prevent resistance to the most effective type of antimalarial agent spreading to the Indian subcontinent and beyond.

  • Launch of new treatment for chronic obstructive pulmonary disease (COPD)

    New treatment for chronic obstructive pulmonary disease

    31 JUL 2014 16:28 By Janna Lawrence

    Olodaterol, a once-daily long acting beta2 agonist inhaler, has been launched in the UK for chronic obstructive pulmonary disease.

  • Royal Court of Justice building

    High Court judge overrules regulator and removes pharmacist from register

    31 JUL 2014 15:49 By Elizabeth Sukkar
    Comments (1)

    A High Court judge has quashed a 12-month suspension decision made by a General Pharmaceutical Council panel and instead removed a pharmacist from the register.

  • No pay rise for hospital pharmacists in past 12 months

    31 JUL 2014 13:21
    Comments (1)

    Hospital pharmacists in England did not get a pay rise for the 12 months ending April 2014, data from the Health and Social Care Information Centre shows.

  • High-power view of nodular mantle cell lymphoma

    Rare blood cancer treatments recommended for approval by the EMA

    31 JUL 2014 13:17 By Elizabeth Sukkar

    The European Medicines Agency has approved two new medicines, ibrutinib (Janssen-Cilag’s Imbruvica) and idelalisib (Gilead Science’s Zydelig), for adult patients with rare blood cancers.

  • Evelina London Children's Hospital awarded at the Patient Safety and Care Awards

    Evelina pharmacy team scoops Patient Safety and Care Award

    31 JUL 2014 10:20 By Graeme Smith

    A pharmacy team from the Evelina London Children’s Hospital has won an award at the inaugural Patient Safety and Care Awards.

  • Robotic production of monoclonal antibodies

    New treatment for Castleman's disease

    31 JUL 2014 8:31 By Janna Lawrence

    A new monoclonal antibody, siltuximab, has been launched in the UK to treat the rare disorder multicentric Castleman disease, which has similarities to lymphoma.

  • Legislation on decriminalising dispensing errors drafted but not yet public

    30 JUL 2014 18:03

    UK parliamentary lawyers have approved draft legislation on decriminalising dispensing errors but timetable for law change is still tight, according to government papers.

  • Endothelial Focal Adhesion Kinase (FAK)

    Protein identified that increases resistance to chemotherapy Subscription

    30 JUL 2014 12:11

    Researchers from Barts Cancer Institute have identified a role for endothelial Focal Adhesion Kinase (FAK) in regulating tumour chemosensitivity.

  • Coloured micrograph of protein filaments or amyloids in alzheimer

    Scientists engineer ‘α-sheet’ to neutralise amyloid proteins Subscription

    30 JUL 2014 11:57

    Researchers have confirmed the existence of a toxic intermediary in the development of amyloid proteins and have designed a protein to neutralise it.

  • The BMJ warns over withheld dabigatran analyses

    29 JUL 2014 12:47

    Boehringer Ingelheim failed to share information about the potential safety benefits of monitoring the anticoagulant activity of dabigatran with regulators, an investigation by The BMJ has claimed.

  • Community pharmacists identify people at risk of diabetes Subscription

    29 JUL 2014 11:50

    Pharmacists can identify patients who have an increased risk of developing type 2 diabetes, research by the University of East Anglia and Boots UK confirms.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.